Insights on Identify HCPs’ preferences and prescription trends for diabetes drugs

Kindly select your most preferred line of treatment after Metformin –

Kindly select your most preferred second line of treatment in patients with high CV risk –

Kindly select your most preferred second line of treatment in obese patients –

Kindly select your most preferred second line of treatment in patients at high risk of hypoglycemia –

Among the following, kindly select your most preferred molecule in DPP4i class –

Kindly select the reason for your preference of the above molecule –

Kindly select a patient profile in which you are most likely to select Vildagliptin –

Kindly select your most preferred dose of Vildagliptin in your patients –

Amongst the following, kindly select your most preferred molecule in the SGLT2i class –

Kindly select the reason for your preference of the above molecule –